October 09, 2026
October 09, 2026
Medical debt linked to higher late-stage cancer rates
October 09, 2026
CDC flags neuro symptoms after unapproved botulinum toxin
October 08, 2026
Case links red light mask to secondary glaucoma
October 07, 2026
FDA approves first therapy for symptomatic dermographism
October 06, 2026
Reading Skin Cancer’s Molecular Fingerprint
Latest Headlines
View More
October 09, 2026
FDA approves pritelivir for refractory HSV lesions
October 09, 2026
Medical debt linked to higher late-stage cancer rates
October 09, 2026
CDC flags neuro symptoms after unapproved botulinum toxin
October 08, 2026
Case links red light mask to secondary glaucoma
October 07, 2026
FDA approves first therapy for symptomatic dermographism
October 06, 2026
Reading Skin Cancer’s Molecular Fingerprint
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Trending Now
1
FDA approves first therapy for symptomatic dermographism
2
Gene may signal declining hair tensile resistance
3
FDA approves pritelivir for refractory HSV lesions
4
CDC flags neuro symptoms after unapproved botulinum toxin
5
Lasers trigger pigmentation from past gold therapy
6
AI may stumble on acne diagnosis
Conference Coverage
Cleveland Clinic's AI Summit for Healthcare Professionals
September 24, 2026
AI in medicine: 'Not everything is what it appears to be'
September 18, 2026
AI’s evolving role in clinical care
2026 ASCRS Annual Meeting
April 11, 2026
Combining MIGS With Implant Lowers IOP in Glaucoma
2026 ASCO GI CANCERS
Clinical Guidelines
View More
Commentary & Perspectives
View More
June 19, 2026
Sunscreen Myths Draw TikTok Engagement
June 17, 2026
Earlier Egg Intake Linked to Less Allergy
May 08, 2026
Fabricated Citations Are Reaching Medical Journals
April 16, 2026
Not All Vitamin C Serums Penetrate the Same
FDA & Government News
View More
October 09, 2026
FDA approves pritelivir for refractory HSV lesions
October 09, 2026
CDC flags neuro symptoms after unapproved botulinum toxin
October 07, 2026
FDA approves first therapy for symptomatic dermographism
September 25, 2026
FDA monthly preview: Key October decisions to watch
Business Management
View More
August 27, 2026
10 states that support physician work-life balance
